Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Distribution of cyclosporine A in ocular tissues after topical administration of cyclosporine A cationic emulsions to pigmented rabbits.

Daull P, Lallemand F, Philips B, Lambert G, Buggage R, Garrigue JS.

Cornea. 2013 Mar;32(3):345-54. doi: 10.1097/ICO.0b013e31825e83f4.

PMID:
23023401
2.

In vitro and in vivo evaluation of a preservative-free cationic emulsion of latanoprost in corneal wound healing models.

Liang H, Baudouin C, Daull P, Garrigue JS, Buggage R, Brignole-Baudouin F.

Cornea. 2012 Nov;31(11):1319-29. doi: 10.1097/ICO.0b013e318255a7f8.

PMID:
22929154
3.

Treating early choroidal neovascularisation with pegaptanib sodium in patients with neovascular age-related macular degeneration: findings of the PERSPECTIVES study.

Chakravarthy U, Staurenghi G, Kwok K, Tressler CS, Buggage R; PERSPECTIVES Study Group.

Br J Ophthalmol. 2012 Oct;96(10):1351-4. Epub 2012 Aug 7. No abstract available.

PMID:
22872673
4.

A comparative study of a preservative-free latanoprost cationic emulsion (Catioprost) and a BAK-preserved latanoprost solution in animal models.

Daull P, Buggage R, Lambert G, Faure MO, Serle J, Wang RF, Garrigue JS.

J Ocul Pharmacol Ther. 2012 Oct;28(5):515-23. Epub 2012 Jun 6.

PMID:
22671995
5.

Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb.

Lallemand F, Daull P, Benita S, Buggage R, Garrigue JS.

J Drug Deliv. 2012;2012:604204. doi: 10.1155/2012/604204. Epub 2012 Feb 27.

6.

Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis.

Chakravarthy U, Wong TY, Fletcher A, Piault E, Evans C, Zlateva G, Buggage R, Pleil A, Mitchell P.

BMC Ophthalmol. 2010 Dec 13;10:31. doi: 10.1186/1471-2415-10-31. Review.

7.

Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.

Wroblewski JJ, Wells JA 3rd, Adamis AP, Buggage RR, Cunningham ET Jr, Goldbaum M, Guyer DR, Katz B, Altaweel MM; Pegaptanib in Central Retinal Vein Occlusion Study Group.

Arch Ophthalmol. 2009 Apr;127(4):374-80. doi: 10.1001/archophthalmol.2009.14.

PMID:
19365011
8.

Pituitary adenoma presenting as bilateral bullous exudative retinal detachments: a clinicopathologic report.

Williams P, Chan CC, Buggage R, Srivastava S, Callanan D.

Retin Cases Brief Rep. 2009 Spring;3(2):230-2. doi: 10.1097/ICB.0b013e31815f3cac.

PMID:
25391084
9.

Gene expression profiling in autoimmune noninfectious uveitis disease.

Li Z, Liu B, Maminishkis A, Mahesh SP, Yeh S, Lew J, Lim WK, Sen HN, Clarke G, Buggage R, Miller SS, Nussenblatt RB.

J Immunol. 2008 Oct 1;181(7):5147-57.

10.

Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.

Singerman LJ, Masonson H, Patel M, Adamis AP, Buggage R, Cunningham E, Goldbaum M, Katz B, Guyer D.

Br J Ophthalmol. 2008 Dec;92(12):1606-11. doi: 10.1136/bjo.2007.132597. Epub 2008 Jul 9.

11.

High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.

Yeh S, Wroblewski K, Buggage R, Li Z, Kurup SK, Sen HN, Dahr S, Sran P, Reed GF, Robinson R, Ragheb JA, Waldmann TA, Nussenblatt RB.

J Autoimmun. 2008 Sep;31(2):91-7. doi: 10.1016/j.jaut.2008.05.001. Epub 2008 Jun 20.

12.

[Humanistic burden and health resource utilization among neovascular age-related macular degeneration patients in France].

Soubrane G, Zlateva G, Xu X, Buggage R, Kosa M.

J Fr Ophtalmol. 2008 Feb;31(2):138-45. French.

13.

Intravitreal methotrexate resistance in a patient with primary intraocular lymphoma.

Sen HN, Chan CC, Byrnes G, Fariss RN, Nussenblatt RB, Buggage RR.

Ocul Immunol Inflamm. 2008 Jan-Feb;16(1):29-33. doi: 10.1080/09273940801899764.

14.

Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss.

Arias L, Armadá F, Donate J, García-Arumí J, Giralt J, Pazos B, Piñero A, Martínez F, Mondéjar JJ, Ortega I, Zlateva G, Buggage R.

Eye (Lond). 2009 Feb;23(2):326-33. doi: 10.1038/sj.eye.6703053. Epub 2008 Jan 18.

PMID:
18202712
15.

Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.

Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.

Pharmacoeconomics. 2008;26(1):57-73.

PMID:
18088159
16.

Burden and health care resource utilization in neovascular age-related macular degeneration: findings of a multicountry study.

Soubrane G, Cruess A, Lotery A, Pauleikhoff D, Monès J, Xu X, Zlateva G, Buggage R, Conlon J, Goss TF.

Arch Ophthalmol. 2007 Sep;125(9):1249-54.

PMID:
17846366
17.

The natural history and prognosis of neovascular age-related macular degeneration: a systematic review of the literature and meta-analysis.

Wong TY, Chakravarthy U, Klein R, Mitchell P, Zlateva G, Buggage R, Fahrbach K, Probst C, Sledge I.

Ophthalmology. 2008 Jan;115(1):116-26. Epub 2007 Aug 6. Review. Erratum in: Ophthalmology. 2008 Sep;115(9):1524. Wong, Tien [corrected to Wong, Tien Y].

PMID:
17675159
18.

A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease.

Buggage RR, Levy-Clarke G, Sen HN, Ursea R, Srivastava SK, Suhler EB, Altemare C, Velez G, Ragheb J, Chan CC, Nussenblatt RB, Bamji AT, Sran P, Waldmann T, Thompson DJ.

Ocul Immunol Inflamm. 2007 Mar-Apr;15(2):63-70.

19.

Progressive outer retinal necrosis in the era of highly active antiretroviral therapy: successful management with intravitreal injections and monitoring with quantitative PCR.

Yin PD, Kurup SK, Fischer SH, Rhee HH, Byrnes GA, Levy-Clarke GA, Buggage RR, Nussenblatt RB, Mican JM, Wright ME.

J Clin Virol. 2007 Mar;38(3):254-9. Epub 2007 Feb 5.

PMID:
17280866
20.

Gamma interferon assay as an alternative to PPD skin testing in selected patients with granulomatous intraocular inflammatory disease.

Kurup SK, Buggage RR, Clarke GL, Ursea R, Lim WK, Nussenblatt RB.

Can J Ophthalmol. 2006 Dec;41(6):737-40.

PMID:
17224956
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk